A Study of Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV)
Clinical trial NCT04583280 · TERMINATED
Trial details
- NCT number
- NCT04583280
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-06
- Primary completion
- 2022-03-18
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.